Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07041125 · ClinicalTrials.gov registry record
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
A clinical trial of PFA Ablation and LAAC Procedures, sponsored by Heart Rhythm Clinical and Research Solutions.
- Recruiting
- Registry status
- 120
- Enrollment target
- 11
- Study locations
NCT07041125 is a study of PFA Ablation and LAAC Procedures that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 120 participants. The trial reports 11 study locations across 9 states.
The verdict
NCT07041125, a study of PFA Ablation and LAAC Procedures, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 11
- Study locations
Study Summary
This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
Conditions Studied
Interventions
- DEVICE Watchman FLX™ Pro device.
Study Locations (11)
Florida
- Arrhythmia Center of South Florida - Delray Beach
- Ascension St. Vincent's Jacksonville - Jacksonville
- HCA Research Institute- Mercy Hospital - Miami
Alabama
- Arrhythmia Institute at Grandview - Birmingham
Indiana
- Ascension St Vincent -Indianapolis Ascension Health - Indianapolis
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Kentucky
- Norton Heart & Vascular Institute - Louisville
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Utah
- St, Mark's Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07041125
The ClinicalTrials.gov registry entry for NCT07041125 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PFA Ablation and LAAC Procedures appearing as the primary indexed condition, and to 1 intervention - of which Watchman FLX™ Pro device. is the first listed.
NCT07041125 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Florida, Alabama, Indiana.
Frequently Asked Questions
What is clinical trial NCT07041125 about?
NCT07041125 is a clinical study titled "Concomitant LAAC/AF Ablation (Watchman FLX Pro)". This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
What is the current status of trial NCT07041125?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-06-01. Estimated completion is 2026-10-30.
What conditions does trial NCT07041125 study?
This clinical trial studies the following conditions: PFA Ablation and LAAC Procedures.
What interventions are being tested in trial NCT07041125?
The interventions under investigation include: Watchman FLX™ Pro device. (DEVICE).
Who is sponsoring clinical trial NCT07041125?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07041125 being conducted?
This trial has 11 study locations across Alabama, Florida, Indiana, Iowa, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.